Familial Cancer

, Volume 6, Issue 1, pp 121–129 | Cite as

The interval between cancer diagnosis among mothers and offspring in a population-based cohort

  • Ora Paltiel
  • Yehiel Friedlander
  • Lisa Deutsch
  • Rebecca Yanetz
  • Ronit Calderon-Margalit
  • Efrat Tiram
  • Hagit Hochner
  • Micha Barchana
  • Susan Harlap
  • Orly Manor
Original Paper

Abstract

Background

Familial cancers may be due to shared genes or environment, or chance aggregation. We explored the possibility that ascertainment bias influences cancer detection in families, bearing upon the time interval between diagnosis of affected mothers and offspring.

Methods

The Jerusalem Perinatal Study (JPS) comprises all mothers (n = 39,734) from Western Jerusalem who gave birth 1964 –1976 and their offspring (n = 88,829). After linking identification numbers with Israel’s Cancer Registry we measured the absolute time interval between initial cancer diagnoses in affected mother-offspring pairs. We tested the probability of obtaining intervals as short as those observed by chance alone, using a permutation test on the median interval.

Results

By June 2003 cancer had developed in 105 mother-offspring pairs within the cohort. Common sites among mothers were breast (47%), colorectal (9%), non-Hodgkin lymphoma (NHL) (8%) and cervix (7%), while for offspring in affected pairs common cancers were leukemia (12.4%), thyroid (13.3%), NHL (10.5%), breast (10.5%) and melanoma (7.6%). The median interval between diagnoses was 5.9 years, but for 33% of affected pairs the interval was ≤3 years. The probability of this occurring by chance alone was 0.03. This held true whether the offspring’s or mother’s diagnosis was first (P < 0.01).

Conclusions

In a population-based cohort followed for three decades, the absolute interval between the diagnosis of cancer in mothers and their offspring is shorter than expected by chance. Explanations include shared environmental exposures or the possibility that cancer ascertainment in one pair member affects health behaviors in the other resulting in early diagnosis. The latter may bias the estimation of anticipation and survival in familial cancers.

Keywords

Hereditary cancer Time to diagnosis Ascertainment bias Cohort study 

References

  1. 1.
    Hemminki K, Li X (2004) Familial risk in testicular cancer as a clue to a heritable environmental aetiology. Br J Cancer 90:1765–1770PubMedCrossRefGoogle Scholar
  2. 2.
    Nagy R, Sweet K, Eng C (2004) Highly penetrant hereditary cancer syndromes. Oncogene 23:6445–6470PubMedCrossRefGoogle Scholar
  3. 3.
    Li FP, Fraumeni JF (1969) Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst 43:1365–1373PubMedGoogle Scholar
  4. 4.
    Wiernik PH, Ashwin M, Hu X et al (2001) Anticipation in familial chronic lymphocytic leukemia. Brit J Haematol 113:407–414CrossRefGoogle Scholar
  5. 5.
    Shugart YY, Hemminki K, Vaittinen P et al (2001) Apparent anticipation and heterogeneous transmission patterns in familial Hodgkin’s and non-Hodgkin’s Lymphoma: report from a study based on Swedish cancer database. Leuk Lymphoma 42:407–415PubMedCrossRefGoogle Scholar
  6. 6.
    Wiernik PH, Wang SQ, Hu X et al (2000) Age of onset evidence for anticipation in familial non-Hodgkin’s lymphoma. Brit J Haematol 108:72–79CrossRefGoogle Scholar
  7. 7.
    Rodriguez-Bigas MA, Lee PH, O’Malley L et al (1996) Establishment of a hereditary nonpolyposis colorectal cancer registry. Dis Colon Rectum 39:649–653PubMedCrossRefGoogle Scholar
  8. 8.
    Dagan E, Gershoni-Baruch R (2002) Anticipation in hereditary breast cancer. Clin Genet 62:147–150PubMedCrossRefGoogle Scholar
  9. 9.
    Harper PS, Harley HG, Reardon W et al (1992) Anticipation in myotonic dystrophy: new light on an old problem. Am J Hum Genet 51:10–16PubMedGoogle Scholar
  10. 10.
    Tsai YY, Petersen GM, Booker SV et al (1997) Evidence against genetic anticipation in familial colorectal cancer. Genet Epidemiology 14:435–446PubMedCrossRefGoogle Scholar
  11. 11.
    Goldin LR, Pfeiffer RM, Li X et al (2004) Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database. Blood 104:1850–1854PubMedCrossRefGoogle Scholar
  12. 12.
    Vineis P (2004) Individual susceptibility to carcinogens. Oncogene 23:6477–6483PubMedCrossRefGoogle Scholar
  13. 13.
    Stiller CA (2004) Epidemiology and genetics of childhood cancer. Oncogene 23:6429–6444PubMedCrossRefGoogle Scholar
  14. 14.
    Olsen JH, Boice JD, Seersholm N et al (1995) Cancer in the parents of children with cancer. N Engl J Med 333:1594–1599PubMedCrossRefGoogle Scholar
  15. 15.
    Pang D, McNally R, Kelsey A et al (2003) Cancer incidence and mortality among the parents of a population-based series of 2604 children with cancer. Cancer Epidemiol Biomarkers Prev 12:538–544PubMedGoogle Scholar
  16. 16.
    Hemminki K, Vaittinen P (1997) Effect of paternal and maternal cancer on cancer in the offspring: a population-based study. Cancer Epidemiol Biomarkers Prev 6:993–997PubMedGoogle Scholar
  17. 17.
    Hemminki K, Li X, Plna K et al (2001) The Nation-wide Swedish Family-Cancer Database. Acta Onc 40:772–777CrossRefGoogle Scholar
  18. 18.
    Dong C, Hemminki K (2001) Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. Int J Cancer 92:144–150PubMedCrossRefGoogle Scholar
  19. 19.
    Hemminki K, Mutanen P (2001) Parental cancer as a risk factor for nine common childhood malignancies. Br J Cancer 84:990–993PubMedCrossRefGoogle Scholar
  20. 20.
    Grossman SA, Osman M, Hruban R et al (1999) Central nervous system cancers in first-degree relatives and spouses. Cancer Invest 17:299–308PubMedCrossRefGoogle Scholar
  21. 21.
    Harlap S, Davies AM, Grover NB et al (1977) The Jerusalem perinatal study: the first decade 1964–73. Isr J Med Sci 13:1073–1091PubMedGoogle Scholar
  22. 22.
    Davies AM, Prywes R, Tzur B et al (1969) The Jerusalem perinatal study. 1. Design and organization of a continuing, community-based, record linked survey. Isr J Med Sci 5:1095–1106PubMedGoogle Scholar
  23. 23.
    Steinitz R, Parkin DM, Young JL, et al. Cancer incidence in Jewish migrants to Israel, 1961–1981. (1989) In Steinitz R, Parkin DM, Young JL, Bieber CA, Katz L (eds) Vol 98. IARC Sci Publ, pp 6–7Google Scholar
  24. 24.
    International classification of disease for oncology: morphology of neoplasms (2000) 3rd ednGoogle Scholar
  25. 25.
    Watson P, Lynch HT (2001) Cancer risk in mismatch repair gene mutation carriers. Familial Cancer 1:57–60PubMedCrossRefGoogle Scholar
  26. 26.
    Lynch HT (2000) Anticipation in familial Hodgkin’s lymphoma. Hum Genet 107:290–293PubMedCrossRefGoogle Scholar
  27. 27.
    Hoh J, Heitjan DF, Merette C et al (2001) Ascertainment and anticipation in family studies. Hum Hered 51:23–26PubMedCrossRefGoogle Scholar
  28. 28.
    King M, Marks JH, (2003) Mandell JB for the New York Breast Cancer Study Group Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643–645PubMedCrossRefGoogle Scholar
  29. 29.
    Bermejo JL, Hemminki K (2005) Familial risk of cancer shortly after diagnosis of the first familial tumor. JNCI 97:1575–9PubMedGoogle Scholar
  30. 30.
    Wellisch DK, Gritz ER, Schain W et al (1991) Psychological functioning of daughters of breast cancer patients. Part I: Daughters and comparison subjects. Psychosomatics 32:324–336PubMedGoogle Scholar
  31. 31.
    Lerman C, Daly M, Sands C et al (1993) Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst 85:1074–1080PubMedCrossRefGoogle Scholar
  32. 32.
    Grootenhuis MA, Last BF (1997) Adjustment and coping by parents of children with cancer: a review of the literature. Support Care Cancer 5:466–484PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media B.V. 2007

Authors and Affiliations

  • Ora Paltiel
    • 1
    • 4
  • Yehiel Friedlander
    • 1
  • Lisa Deutsch
    • 1
  • Rebecca Yanetz
    • 1
  • Ronit Calderon-Margalit
    • 1
  • Efrat Tiram
    • 1
  • Hagit Hochner
    • 1
  • Micha Barchana
    • 2
  • Susan Harlap
    • 3
  • Orly Manor
    • 1
  1. 1.Braun School of Public HealthHadassah-Hebrew UniversityJerusalemIsrael
  2. 2.Israel Cancer RegistryMinistry of HealthJerusalemIsrael
  3. 3.Mailman School of Public HealthColumbia UniversityNew YorkUSA
  4. 4.School of Public HealthJerusalemIsrael

Personalised recommendations